Febantel

The exact presentation is actively registered in Georgia. Clinical instructions use the same-manufacturer, same-strength current UK Krka Multiwormer SPC rather than a public document carrying the Dehinel trade name, so exact-brand transparency is one step below Drontal.

The established febantel-pyrantel-praziquantel combination has strong class and field support for susceptible canine intestinal nematodes and cestodes. This exact label is narrower than Drontal Tasty: no whipworm, Echinococcus or Giardia claim should be imported.

Very rare transient gastrointestinal or nonspecific signs are expected, but the first two-thirds of pregnancy, age under two weeks, weight below 2 kg, piperazine, cholinergic and selected interacting drugs require explicit screening.

The flavoured cross-scored tablet supports quarter-tablet dosing from just over 2 kg through 40 kg and can be given directly or with food. It has no labelled dose above 40 kg and should not be extrapolated.

The exact bone-shaped 150/144/50 mg presentation is actively registered in Georgia and has a current exact HPRA SPC plus a multi-country EU authorisation trail.

The full helminth label is supported by recent exact-brand field evidence and longer controlled field data. A small randomized trial supports the three-day Giardia claim, but incomplete clearance in some dogs and diagnostic uncertainty prevent treating every diarrhoeic dog empirically.

Adverse events are very rare and usually mild/transient, but early pregnancy is contraindicated, cholinergic or piperazine combinations can be hazardous, and resistance or underdosing remains possible.

The palatable bone-shaped tablet is voluntarily accepted by most tested dogs, divides into halves, works with or without food and follows a simple 1-tablet/10-kg rule. A retained half is limited to seven days and Giardia requires three doses.

The exact strength and presentation are actively registered in Georgia and supported by an exact HPRA SPC. The dossier is transparent, although its cited revision is older than the newest Tasty formulation label.

The three-drug combination has controlled and field evidence against susceptible canine intestinal nematodes and cestodes and the exact label covers adult and selected immature stages. It does not replace diagnosis, risk-based scheduling or intermediate-host control.

Adverse effects are very rare and usually mild/transient, with useful overdose tolerance. Piperazine and cholinergic combinations, pregnancy dosing, hypersensitivity, minimum weight and human Echinococcus risk still require safeguards.

A single flavoured half-tablet-step dose can be given directly or with food without fasting and extends above 40 kg by the labelled 1-tablet/10-kg rule. It is unsuitable below 3 kg and unused parts must be discarded.

The exact product is registered in Georgia (000962, valid to 2030) and has a Turkish product record naming the marketing-authorisation holder and manufacturer with a full label, but no EU, UK or US authorisation was documented in the reviewed evidence or product-specific study.

It has the Drontal Plus composition at the same 1 tablet per 10 kg, a regimen with strong evidence against roundworms, hookworms, whipworms and tapeworms including Echinococcus; bioequivalence of this generic is not public.

The label is complete: no use below 2 kg, below 4 weeks or in the first two-thirds of pregnancy, clear interaction warnings, and only rare mild vomiting, anorexia or diarrhoea.

Individually sachet-packed tablets with half-tablet bands from 2 to 40 kg, given directly or with food and without fasting, make dosing straightforward.